2 Spam-Free Article(s) Found
Sort:
Date
Filter:
7d
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
NVO Novo Nordisk A/S $47.64 $114.84B Buy
Article Searches
Novo Nordisk Has Managed The Turnaround https://seekingalpha.com/article/4240750-novo-nordisk-managed-turnaround?source=feed_sector_healthcare Feb 13, 2019 - Novo Nordisk reported full year results for 2018, and while revenue was still stagnant, earning per share could grow 4%.Due to the launch of new products like Saxenda, Ozempic, and Oral Semaglutide, N
Seattle Genetics' Adcetris Gets EC Nod for Label Expansion http://www.zacks.com/stock/news/354019/seattle-genetics-adcetris-gets-ec-nod-for-label-expansion?cid=CS-ZC-FT-354019 Feb 12, 2019 - Seattle Genetics' (SGEN) partner, Takeda Pharmaceutical receives EC approval for Adcetris in combination with AVD to treat adults with previously untreated CD30+ stage IV cHL.

Pages: 1

Page 1

Related Companies

Name Exchange Price Mkt Cap
LLY Eli Lilly and Company NYSE $105.71 $113.53B
ABT Abbott Laboratories NYSE $67.67 $118.71B
SNY Sanofi NYSE $43.75 $109.14B
BMY Bristol-Myers Squibb Company NYSE $61.3 $100.03B
GSK GlaxoSmithKline PLC NYSE $39.21 $97.25B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Novo Nordisk A/S
NVO - Google Finance https://www.google.com/finance?q=NVO Industry related info and international coverage Summary News
NVO - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=NVO Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options